Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trial

导出原文传递

翻译打印收藏纠错

作者： Ishoy, Pelle L. ^[1] ; Knop, Filip K. ^[2] ; Broberg, Brian V. ^[3] ; Bak, Nikolaj ^[4] ; Andersen, Ulrik B. ^[5] ; Jorgensen, Niklas R. ; Holst, Jens J. ; Glenthoj, Birte Y. ; Ebdrup, Bjorn H.

作者单位： Univ Copenhagen, Dept Clin Physiol Nucl Med & PET, Rigshosp, Glostrup, Denmark ^[1] Univ Copenhagen, Res Ctr Ageing & Osteoporosis, Dept Clin Biochem, Rigshosp, Glostrup, Denmark ^[2] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth & Med Sci, Copenhagen, Denmark ^[3] Univ Copenhagen, Ctr Neuropsychiat Schizophrenia Res, CNSR, Glostrup, Denmark ^[4] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark ^[5]

关键词 antidiabetic drug exenatide GLP-1 analogue randomized trial schizophrenia

发布时间 2017-05-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交